CN1535314A - 同源性犬埃里希体28千道尔顿免疫优势蛋白质基因及其用途 - Google Patents

同源性犬埃里希体28千道尔顿免疫优势蛋白质基因及其用途 Download PDF

Info

Publication number
CN1535314A
CN1535314A CNA998137820A CN99813782A CN1535314A CN 1535314 A CN1535314 A CN 1535314A CN A998137820 A CNA998137820 A CN A998137820A CN 99813782 A CN99813782 A CN 99813782A CN 1535314 A CN1535314 A CN 1535314A
Authority
CN
China
Prior art keywords
ser
seq
gly
phe
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA998137820A
Other languages
English (en)
Chinese (zh)
Inventor
D��H���ֿ�
D·H·沃克
于学杰
J·W·麦克布里奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RESEARCH DEVELOPMENT FOUDATION
Original Assignee
RESEARCH DEVELOPMENT FOUDATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/201,458 external-priority patent/US6458942B1/en
Application filed by RESEARCH DEVELOPMENT FOUDATION filed Critical RESEARCH DEVELOPMENT FOUDATION
Publication of CN1535314A publication Critical patent/CN1535314A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CNA998137820A 1998-11-30 1999-11-24 同源性犬埃里希体28千道尔顿免疫优势蛋白质基因及其用途 Pending CN1535314A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/201,458 1998-11-30
US09/201,458 US6458942B1 (en) 1998-11-30 1998-11-30 28-kDa immunoreactive protein gene of Ehrlichia canis and uses thereof
US09/261,358 US6403780B1 (en) 1998-11-30 1999-03-03 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
US09/261,358 1999-03-03

Publications (1)

Publication Number Publication Date
CN1535314A true CN1535314A (zh) 2004-10-06

Family

ID=26896771

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA998137820A Pending CN1535314A (zh) 1998-11-30 1999-11-24 同源性犬埃里希体28千道尔顿免疫优势蛋白质基因及其用途

Country Status (11)

Country Link
EP (1) EP1470223A4 (enExample)
JP (1) JP2003527073A (enExample)
CN (1) CN1535314A (enExample)
AU (1) AU762315B2 (enExample)
BR (1) BR9916141A (enExample)
CA (1) CA2352466A1 (enExample)
IL (1) IL143415A0 (enExample)
NZ (1) NZ511922A (enExample)
RU (1) RU2237716C2 (enExample)
TW (1) TWI221481B (enExample)
WO (1) WO2000032745A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544517B1 (en) 1998-09-18 2003-04-08 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US7888491B2 (en) 1998-09-18 2011-02-15 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US6392023B1 (en) * 1999-03-03 2002-05-21 Research Development Foundation Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof
US7335754B2 (en) 1999-07-21 2008-02-26 Cornell Research Foundation, Inc. Ehrlichia canis genes and vaccines
CA2407946A1 (en) 2000-05-01 2001-11-08 Research Development Foundation Ehrlichia chaffeensis 28 kda outer membrane protein multigene family
US6432649B1 (en) * 2000-08-25 2002-08-13 The Ohio State University Research Foundation Methods for detecting Ehrlichia canis and Ehrlichia chaffeensis in vertebrate and invertebrate hosts
US8784828B2 (en) 2007-05-04 2014-07-22 The Ohio State University Research Foundation Ehrlichia ewingii proteins, nucleic acids, and methods of their use
US20140162256A1 (en) 2011-03-31 2014-06-12 Yasuko Rikihisa Compositions and methods for the detection of anaplasma platys
CN105051541B (zh) 2012-10-11 2017-07-04 爱贝斯股份有限公司 用于检测埃里希体属抗体的肽、装置和方法
US9442112B2 (en) * 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species
WO2025118050A1 (pt) * 2023-12-04 2025-06-12 Laboratório Bio-Vet Ltda Antígeno vacinal quimérico com ação tríplice contra erliquiose, anaplasmose e babesiose canina, vetor de expressão, célula recombinante, composição vacinal, kit de diagnóstico, método de tratamento e uso de proteína quimérica

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025338A (en) * 1996-10-17 2000-02-15 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
ATE481416T1 (de) * 1997-09-19 2010-10-15 Univ Ohio State Res Found Proteine der äusseren membran von ehrlichia chaffeensis

Also Published As

Publication number Publication date
CA2352466A1 (en) 2000-06-08
TWI221481B (en) 2004-10-01
BR9916141A (pt) 2001-12-04
NZ511922A (en) 2003-10-31
JP2003527073A (ja) 2003-09-16
EP1470223A4 (en) 2005-04-06
RU2237716C2 (ru) 2004-10-10
EP1470223A2 (en) 2004-10-27
WO2000032745A3 (en) 2004-05-21
AU1923400A (en) 2000-06-19
AU762315B2 (en) 2003-06-19
IL143415A0 (en) 2002-04-21
WO2000032745A2 (en) 2000-06-08

Similar Documents

Publication Publication Date Title
CN1473166A (zh) 犬埃里希体的同源28kD免疫优势蛋白质基因及其用途
CN1281747C (zh) 犬埃里希体120－kda免疫优势抗原性蛋白和基因
CN1944652A (zh) B组链球菌抗原
CN1535314A (zh) 同源性犬埃里希体28千道尔顿免疫优势蛋白质基因及其用途
CN1215167C (zh) 幽门螺杆菌活疫苗
CN1735684A (zh) 用于犬和人埃利希病的免疫诊断的p153和p156抗原及其用途
CN1158387C (zh) 编码l.infantum的四种蛋白质的抗原决定簇的嵌合基因
CN1149288C (zh) 来自副鸡嗜血杆菌的新多肽及其制备方法
CN1629188A (zh) 日本血吸虫的特异性抗原及用途
CN1631438A (zh) 人和易感动物0157菌基因工程多价亚单位疫苗及制备方法
CN1629189A (zh) 日本血吸虫的特异性抗原及用途
CN1545552A (zh) 基因和蛋白质及它们的用途
CN1296974A (zh) 一种新的多肽——人组蛋白h2a.21和编码这种多肽的多核苷酸
CN101063141A (zh) 粘膜炎莫拉氏菌(布兰汉氏菌)抗原
CN1272436C (zh) 一种口蹄疫双价多肽疫苗基因合成及高效表达方法
CN1800210A (zh) 治疗感染性疾病和免疫系统疾病的化合物及其使用方法
CN1670197A (zh) 日本血吸虫精氨酸酶，其编码核酸及其应用
CN1345851A (zh) 一种新的多肽——人含组蛋白h3特征序列片段的蛋白11.66和编码这种多肽的多核苷酸
CN1342664A (zh) 一种新的多肽——含WD重复域的G－beta蛋白14.08和编码这种多肽的多核苷酸
CN1772306A (zh) 柯萨奇病毒b组3型基因疫苗
CN1549727A (zh) 粘膜炎莫拉氏(布拉汉氏)菌多肽及相应dna片段
CN1393549A (zh) 一种多肽——胰蛋白酶原－26.51和编码这种多肽的多核苷酸
CN1345884A (zh) 一种新的多肽——半胱氨酸蛋白酶抑制剂10.23和编码这种多肽的多核苷酸
HK1110625A (en) Moraxella(branhamella) catarrhalis antigens
CN1188509A (zh) 抗蛋白酶k降解的脑膜炎奈瑟氏球菌表面蛋白

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication